rs104894427
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014239.4(EIF2B2):c.547C>T(p.Arg183*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000242 in 1,612,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014239.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with vanishing white matterInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina
- leukoencephalopathy with vanishing white matterInheritance: AR Classification: STRONG Submitted by: G2P
- leukoencephalopathy with vanishing white matter 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarioleukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014239.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EIF2B2 | NM_014239.4 | MANE Select | c.547C>T | p.Arg183* | stop_gained | Exon 4 of 8 | NP_055054.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EIF2B2 | ENST00000266126.10 | TSL:1 MANE Select | c.547C>T | p.Arg183* | stop_gained | Exon 4 of 8 | ENSP00000266126.5 | ||
| EIF2B2 | ENST00000553401.5 | TSL:5 | n.520C>T | non_coding_transcript_exon | Exon 4 of 7 | ENSP00000451681.1 | |||
| EIF2B2 | ENST00000553539.1 | TSL:2 | n.842C>T | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151164Hom.: 0 Cov.: 28 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 251026 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461602Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727084 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151164Hom.: 0 Cov.: 28 AF XY: 0.0000271 AC XY: 2AN XY: 73780 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Leukoencephalopathy with vanishing white matter 2 Pathogenic:2
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg183*) in the EIF2B2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EIF2B2 are known to be pathogenic (PMID: 11704758, 12707859). This variant is present in population databases (rs104894427, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of leukoencephalopathy with vanishing white matter (PMID: 12707859). ClinVar contains an entry for this variant (Variation ID: 4338). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at